Target Capture Sequencing

Target Capture Sequencing (TCS) allows researchers to extract genomic information from exons or regions of interest in the human or mouse genome with customized probes. Novogene’s cost-effective TCS technologies, including Whole Exome Sequencing (WES) and Target Region Sequencing (TRS), deliver much higher coverage than whole genome sequencing for the identification of rare variants and can deliver exceptionable prospects for researchers and patients.